Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé

Dafna D. Gladman, Philip J. Mease, Paul Bird, Enrique R. Soriano, Soumya D. Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai Shan Tam, Philip S. Helliwell, Arthur Kavanaugh, Atul A. Deodhar, Mikkel Østergaard, Xenofon Baraliakos

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Article numberannrheumdis-2022-222161
JournalAnnals of the rheumatic diseases
StateAccepted/In press - 2022


  • arthritis, psoriatic
  • cytokines
  • spondylitis, ankylosing

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this